EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Older adult perception of preclinical Alzheimer’s disease screening and treatment

James Hoehns, Bryan Kendall, Kayla Kinney, Deeya Karkera, Eric Macak, Sejin Kim, Matthew Witry

INNOVATIONS in pharmacy · 01.07.2026 · 17 (1)

DOI: 10.24926/iip.v17i1.6958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INNOVATIONS in pharmacy, online erschienen am 01.07.2026. Verfasst von James Hoehns und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Preclinical Alzheimer’s disease (AD) accounts for more than 80% of patients on the AD continuum.

Objective

The objective of this study is to query patient concerns towards their risk of developing preclinical Alzheimer’s disease and assess patient beliefs and preferences towards screening and taking potential preventive therapies.

Methods

An electronic survey assessed older adult perceptions towards their risk of developing preclinical AD, screening, and preventive therapies.

Results

One-hundred eight patients aged 55 to 80 years completed the survey during routine care at a family medicine clinic. Overall, 89% of participants would undergo blood screening for preclinical AD, despite 75% not believing they are at higher risk than peers. When asked about treatment, 83% showed interest in medication treatments, with 71% interested in intravenous (IV) formulations and 61% in subcutaneous formulations. These data show a slight preference for IV formulations. There were no significant differences between demographic groups and willingness to test or treat preclinical AD.

Conclusion

These findings highlight the need for patient-centered approaches to preclinical AD screening and treatment.

Zitieren

APA

Hoehns, J., Kendall, B., Kinney, K., Karkera, D., Macak, E., Kim, S., & Witry, M. (2026). Older adult perception of preclinical Alzheimer’s disease screening and treatment. INNOVATIONS in pharmacy, 17(1). https://doi.org/10.24926/iip.v17i1.6958

Vancouver

Hoehns J, Kendall B, Kinney K, Karkera D, Macak E, Kim S, et al. Older adult perception of preclinical Alzheimer’s disease screening and treatment. INNOVATIONS in pharmacy. 2026;17(1). doi:10.24926/iip.v17i1.6958

BibTeX
@article{Hoehns2026,
  author = {Hoehns, James and Kendall, Bryan and Kinney, Kayla and Karkera, Deeya and Macak, Eric and Kim, Sejin and Witry, Matthew},
  title = {Older adult perception of preclinical Alzheimer’s disease screening and treatment},
  journal = {INNOVATIONS in pharmacy},
  year = {2026},
  volume = {17},
  number = {1},
  doi = {10.24926/iip.v17i1.6958}
}
Kostenlos starten →